Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 16/20 | 0.46 |
| ▸ | HCRTR2 | O43614 | 16/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22250701 | 0.85 | HCRTR1 (0.45) | HCRTR1HCRTR2 | |
| SCHEMBL17843082 | 0.84 | HCRTR1 (0.50) | HCRTR1HCRTR2 | |
| SCHEMBL22242028 | 0.83 | ADORA2A (0.46) | HCRTR1HCRTR2 | |
| SCHEMBL22250098 | 0.83 | HCRTR1 (0.44) | HCRTR1HCRTR2 | |
| SCHEMBL22251076 | 0.82 | HCRTR1 (0.47) | HCRTR1HCRTR2 | |
| SCHEMBL20909900 | 0.81 | HCRTR1 (0.55) | HCRTR1HCRTR2 | |
| SCHEMBL22251063 | 0.79 | HCRTR1 (0.45) | HCRTR1HCRTR2 | |
| SCHEMBL28790836 | 0.79 | HCRTR1 (0.45) | HCRTR1HCRTR2 | |
| SCHEMBL13104652 | 0.77 | HCRTR1 (0.45) | HCRTR1HCRTR2 | |
| SCHEMBL536688 | 0.77 | HCRTR1 (0.42) | HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021146631-A1 | HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS | NUVATION BIO INC. (US) | 2021-07-22 | — | — | WO | disclosed |
| WO-2020150675-A1 | COMPOUNDS AND USES THEREOF | NUVATION BIO INC. (US) | 2020-07-23 | — | — | WO | disclosed |
| WO-2020150677-A1 | HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS | NUVATION BIO INC. (US) | 2020-07-23 | — | — | WO | disclosed |